News
Cancer Survivors and Providers Have Different Views on Medical Cannabis, Study Finds
Findings point to differences in risk perception, communication and confidence discussing cannabis in cancer care.
News
Findings point to differences in risk perception, communication and confidence discussing cannabis in cancer care.
Comment
Sponsored features editor ·
News
Sarah Sinclair ·
Industry
Business of Cannabis ·
Journalism built on science, not speculation.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
See all events4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
In a first-of-its-kind clinical trial, researchers found that people who took THC and CBD had significantly less agitation compared to people who received a placebo.
Since launching its legal support helpline, Releaf Cannabis Clinic has received increasing reports from patients experiencing stigma and discrimination.
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
Science & Evidence — Spotlight
We read the studies so you don’t have to — separating robust findings from headlines, with the methods and caveats laid bare.
Explore the research
Plain-language guides to conditions, cannabinoids and what the evidence actually says.
Explore patient guidesRegulatory change, clinical evidence and the patient perspective for prescribers and pharmacists.
Enter the clinical hubDirectory
Browse verified UK medical cannabis clinics and pharmacies — online and in person.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
See all events4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall